Understanding how African APOE genes protect against Alzheimer's disease
Interrogating the protective effect of African APOE alleles on Alzheimer's disease risk through pleiotropy
This project looks at specific genetic differences in people of African descent that might help protect them from Alzheimer's disease.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11175346 on NIH RePORTER |
What this research studies
This research explores why certain genetic variations, called African-derived APOE alleles, appear to lower the risk of Alzheimer's disease in populations with mixed ancestry, such as African Americans. We aim to identify the exact genetic changes within these protective alleles that are responsible for this effect. Additionally, we will investigate how these protective genes function at a cellular level, focusing on their roles in lipid processing and inflammation. This work could uncover new biological pathways that naturally resist Alzheimer's disease.
Who could benefit from this research
Good fit: This research is relevant to individuals of African descent, particularly those with a family history of Alzheimer's disease, who are interested in the genetic factors influencing their risk.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention will not receive benefit from this foundational genetic research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to identify individuals at lower risk for Alzheimer's or inspire new treatments that mimic these natural protective genetic effects.
How similar studies have performed: Previous work by these researchers and others has already shown an association between African-derived APOE alleles and reduced Alzheimer's risk, making this a follow-up to promising initial findings.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Blue, Elizabeth Eloyce — University of Washington
- Study coordinator: Blue, Elizabeth Eloyce
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.